Filter News
Area of Research
News Topics
- (-) Biomedical (10)
- (-) Frontier (4)
- (-) Isotopes (12)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (2)
- Artificial Intelligence (7)
- Big Data (5)
- Bioenergy (13)
- Biology (23)
- Biotechnology (5)
- Buildings (13)
- Chemical Sciences (7)
- Clean Water (8)
- Climate Change (11)
- Composites (6)
- Computer Science (30)
- Coronavirus (10)
- Critical Materials (4)
- Cybersecurity (5)
- Decarbonization (7)
- Energy Storage (22)
- Environment (39)
- Exascale Computing (2)
- Fusion (8)
- Grid (11)
- High-Performance Computing (19)
- ITER (4)
- Machine Learning (1)
- Materials (32)
- Materials Science (22)
- Mathematics (1)
- Mercury (3)
- Microscopy (10)
- Nanotechnology (10)
- National Security (7)
- Net Zero (1)
- Neutron Science (18)
- Nuclear Energy (6)
- Physics (3)
- Polymers (5)
- Quantum Computing (5)
- Quantum Science (12)
- Security (3)
- Space Exploration (4)
- Statistics (1)
- Summit (9)
- Sustainable Energy (35)
- Transportation (21)
Media Contacts
![Miaofang Chi, a scientist in the Center for Nanophase Materials Sciences, received the 2021 Director’s Award for Outstanding Individual Accomplishment in Science and Technology. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-12/2021-P09692_0.jpg?h=9bbd619b&itok=4iANdQKl)
A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.
![U.S. Secretary of Energy Granholm tours ORNL’s world-class science facilities](/sites/default/files/styles/list_page_thumbnail/public/2021-11/2021-P09409.jpg?h=036a71b7&itok=C8b0_-Vk)
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
![Ashleigh Kimberlin and Mikayla Molnar achieve success with a gas-trapping apparatus for Ac-225 production. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/Acgastrapping-1.png?h=71976bb4&itok=TbfsnNxp)
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
![INCITE_narrow_logo](/sites/default/files/styles/list_page_thumbnail/public/2021-11/incite_narrow_1.png?h=a08abdbb&itok=2O5LBHgQ)
The U.S. Department of Energy’s Office of Science announced allocations of supercomputer access to 51 high-impact computational science projects for 2022 through its Innovative and Novel Computational Impact on Theory and Experiment, or INCITE, program.
![Biopsy from the tubular esophagus showing incomplete intestinal metaplasia, goblet cells with interposed cells having gastric foveolar-type mucin consistent with Barrett esophagus. Negative for dysplasia. H&E stain. Credit: Creative Commons](/sites/default/files/styles/list_page_thumbnail/public/2021-11/1200px-Barrett_esophagus_high_mag%5B1%5D_2.jpg?h=10d202d3&itok=qDgHrzu5)
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
![Former ORNL Director Thom Mason presents Tom Kollie with a National Intelligence Meritorious Unit Citation on behalf of James Clapper, former director of national intelligence, and the national intelligence community in June 2017. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-09/2017-P04637_1.jpg?h=b6236d98&itok=Riz5mhDe)
A 25-year career with the U.S. Navy, commanding combat missions overseas, brought Tom Kollie back to where he came from — ready to serve his country in a new way.
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Initially, Kevin Gaddis’s adapted HPIC will be used only for the fourth of six separations in actinium-225 processing, but he hopes it will later be used for other separations — and other isotopes. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-07/2021-P03893_1.jpg?h=c6980913&itok=DU6L5EUx)
An Oak Ridge National Laboratory researcher has invented a version of an isotope-separating device that can withstand extreme environments, including radiation and chemical solvents.
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.